LI
IRWD icon

Leap Investments’s Ironwood Pharmaceuticals IRWD Stock Holding History

Leap Investments’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-12,400
Closed -$125K – 483
2020
Q1 		$125K Sell
12,400
-38,806
-76% -$456K 0.18% 230
2019
Q4 		$682K Buy
+51,206
New +$565K 0.32% 100

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Leap Investments's IRWD Position: Q2 2020 in Review

Leap Investments sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2020, closing a stake of 12,400 shares — an estimated $125K sold.

Leap Investments first reported a position in IRWD in Q4 2019 and held it in 2 quarters. The position peaked at $682K in Q4 2019. 202 funds tracked by Wall St. Rank hold IRWD as of Q2 2020.

  • Leap Investments reported no remaining Ironwood Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Leap Investments sold 12,400 Ironwood Pharmaceuticals shares in Q2 2020, an estimated $125K.
  • Leap Investments first reported a position in Ironwood Pharmaceuticals in Q4 2019 and held it in 2 quarters.
  • Leap Investments's Ironwood Pharmaceuticals position peaked at $682K in Q4 2019.
  • 202 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.